Balance Sheet Data

Novo Nordisk A/S (NVO)

$118.79

+0.96 (+0.81%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 18,85215,63815,47512,75717,48519,712.5720,904.3122,168.1023,508.2924,929.50
Total Cash (%)
Account Receivables 23,55126,88929,15232,18446,79938,107.6440,411.4742,854.5845,445.3948,192.82
Account Receivables (%)
Inventories 15,37316,33617,64118,53619,62121,311.3922,599.7923,966.0725,414.9626,951.44
Inventories (%)
Accounts Payable 5,6106,7566,3585,7178,8708,086.038,574.889,093.289,643.0210,226
Accounts Payable (%)
Capital Expenditure -8,648-12,410-11,231-22,081-7,385-15,135.10-16,050.10-17,020.43-18,049.41-19,140.60
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.